Meet an IBDIQ contributor /

Sophie M. Balzora, MD, FACG

About Sophie M. Balzora MD, FACG

Sophie M. Balzora, MD, FACG, is a clinical professor of medicine in the Division of Gastroenterology and Hepatology at the New York University Grossman School of Medicine and practicing gastroenterologist with a clinical interest in inflammatory bowel disease (IBD). 

Dr. Balzora is President and co-founder of the Association of Black Gastroenterologists and Hepatologists (ABGH), founded in 2021. Balzora is Chair of the American College of Gastroenterology (ACG)’s Diversity, Equity, and Inclusion Committee and co-founder of ACG’s #DiversityinGI social media campaign. She serves on the ACG Institute’s Leadership, Ethics, and Equity Center Advisory Board, the Color of Crohn’s and Gastrointestinal Illnesses (COGI) Medical Advisory Board and Board of Directors, and on the Board of the Association of Black Princeton Alumni (ABPA). 

Dr. Balzora has published in high-impact journals, including Nature, The Lancet, and Gastroenterology, contributed to pieces in The New York Times and The Washington Post, and featured on Good Morning America and other media outlets for her health equity work. She has been recognized nationally for her contributions to the field as it relates to diversity, equity, inclusion, and health equity, and her health equity advocacy has brought her to Capitol Hill and The White House to work with community, national, and political stakeholders in the advancement of health equity in the digestive disease space.


  • Advisory Board: Takeda, Pfizer, Johnson & Johnson
  • Consultant: Takeda, Pfizer, Bristol Myers Squibb, Johnson & Johnson
  • Speaker/Education: Pfizer